IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q2 2023 Holdings

Filed 2023-08-14 | 3 holdings | $611.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ambrx Biopharma IncSPONSORED ADS02290A102$274.7M16,688,63644.9%
TG Therapeutics Inc(TGTX)COM88322Q108$230.5M9,278,43937.7%
Argenx SE(ARGX)SPONSORED ADR04016X101$106.5M273,34317.4%